Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer
Completed · Phase 2
Conditions studied: Prostate Cancer
In brief
RATIONALE: Androgens can stimulate the growth of prostate cancer cells. Drugs such as goserelin, leuprolide, flutamide, or bicalutamide may stop the adrenal glands from producing androgens. Internal radiation uses radioactive material placed directly into or near a tumor to kill tumor cells. Combining hormone therapy with internal radiation may be effective in treating locally recurrent prostate cancer. PURPOSE: Phase II trial to study the effectiveness of hormone therapy followed by internal radiation in treating patients who have locally recurrent prostate cancer following external-beam radiation therapy.
Key facts
- Study ID
- NCT00032006
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 48
- Starts
- 2002-02-01
- Expected to finish
- 2003-10-01
- Last updated by the study team
- 2016-07-13
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
Where it is running
- CCOP - Scottsdale Oncology Program — Scottsdale, Arizona, United States
- Mayo Clinic — Jacksonville, Florida, United States
- CCOP - Carle Cancer Center — Urbana, Illinois, United States
- CCOP - Iowa Oncology Research Association — Des Moines, Iowa, United States
- Mayo Clinic Cancer Center — Rochester, Minnesota, United States
- CCOP - Missouri Valley Cancer Consortium — Omaha, Nebraska, United States
- Allegheny General Hospital — Pittsburgh, Pennsylvania, United States
- CCOP - St. Vincent Hospital Cancer Center, Green Bay — Green Bay, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.